U.S. health officials are warning about the rising trend of opioid-related ingredients, particularly 7-Hydroxymitragynine (7-OH), being added to energy drinks and supplements sold at gas stations. This compound, derived from the Kratom plant, has gained popularity as an unapproved treatment for conditions like pain and anxiety. The FDA is recommending a nationwide ban on 7-OH, labeling it a potent opioid, and suggesting it be placed on the federal list of illegal drugs, similar to heroin and LSD.
FDA Commissioner Marty McCurry emphasized the need for regulation and public education to prevent further opioid crises. The agency’s recommendations will be reviewed by the Drug Enforcement Bureau, with new rules to be drafted for future enforcement.
Kratom has faced scrutiny for nearly a decade due to reports of poisoning and overdoses, yet its users argue it is a safer alternative to traditional opioids. Recently, the FDA issued warning letters to seven companies for selling 7-OH products that were not evaluated for safety and made misleading health claims.
Despite attempts to regulate Kratom, including a near ban by the DEA in 2016, pushback from users and distributors has stalled those efforts. The FDA has issued continued warnings over Kratom’s addictive qualities, as well as concerning other unapproved supplements and substances.
Source link
